Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Bank of Montreal launch of four new series of exchange traded notes on NYSE Arca
We advised Bank of Montreal on the launch of U.S. Big Banks and U.S. Big Oil leveraged and inverse leveraged ETNs
Wayfair $700 million senior secured notes offering
The high-yield notes are due 2030
British American Tobacco $2.5 billion notes offering
The offering is composed of three tranches of notes
Alkami Technology $345 million convertible senior notes offering
The 1.5% convertible notes are due 2030
First Citizens BancShares $1.25 billion notes offering
The investment-grade notes are due 2031 and 2040
Bank of America €3.25 billion senior notes offering
The investment-grade debt offering consists of two tranches
Spirit Airlines emerges from chapter 11
We advised Spirit in connection with its chapter 11 cases
Primo Brands $1.5 billion debut secondary offering
The shares are listed on the New York Stock Exchange
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Axon Enterprise $1.75 billion senior notes offering
The high-yield notes are due 2030 and 2033